Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Preferred Dental Technologies Announces 3D Technology Breakthrough that brings its Game Changing Technology to the Forefront


Posted on: 22 Nov 17

WINNIPEG, Manitoba, Nov. 22, 2017 (GLOBE NEWSWIRE) -- Preferred Dental Technologies Inc. (Company”) (CSE:PDT) announces 3D Technology Breakthrough that brings its game changing technology to the forefront.

The Company is the only dental implant company with the ability to 3D print solid custom dental abutments.

The Company is extremely excited to report that its entry into the digital market exceeds initial expectations.  In defining the parameters of milling custom dental abutments, the Company determined that the same platform can be used successfully in 3D printing.  This has been further validated with initial prototypes printed with high precision plastics and further printed in castable wax and direct to metal.

The importance of this revolutionary breakthrough is not limited to the huge savings in time offered by 3D printing technology, but more importantly results in decreased production costs of individual abutments.  Custom abutments can now be prototyped and manufactured in house with minimal capital cost.

In a test run of prototypes, twelve custom angled abutments were created in a total of twenty-seven minutes.  This was accomplished using only a fraction of the printing area, leaving a lot of area to print crowns, bars, bridges and other necessary dental implant components.  An entire case or multiple cases can be printed all at the same time depending on case load.  The features of the Evolutionary Accessory Series (EAS) are still maintained through all aspects of production, whether using the universal EAS platform in a traditional manner, CAD/CAM milling or 3D printing. It provides correction of angulation, parallelism and fixation screw loosening problems while still being easily retrievable on even the most complex restorative cases.

Production comparisons to what is available in the dental market today are noted below.

  • Twelve EAS 3D printed custom abutments in twenty-seven minutes,
  • Milling one custom abutment typically takes 45 minutes to one hour and fifteen minutes
  • Traditional casting of the EAS takes two to two and a half hours depending on the technician's skillset
  • A UCLA style custom abutment takes the better part of a day to complete one unit.

There is a clear time and cost benefit with using the EAS platform in addition to solving problems that contribute to common dental implant failures.  The Company looks forward to commercial launch within next fiscal year. 

A growing number of dental labs use 3D printing technology to create their own bridges, overdenture bars, models and crowns.  PDT’s solution can be seamlessly integrated and adopted in their daily routine, using an economical in house 3D printer.  This eliminates sending out cases for manufacturing, eliminating outsourcing allows technicians to maintain case control while improving their operating margins.  There will no longer be a need to pay someone else to do what you can do in your own office.

Advisor Rodrigo França, D.D.S, M.Sc, Ph.D. stated, "The unique features of the EAS System like control over angulation, easy screw retention and perfect parallelism make this system a game-changer for solving complex cases.  The 3D printed prototypes of EAS System is an elegant and avant-garde solution to provide better care to patients."

About PDT
Preferred Dental technologies Inc. (PDT) has been established to advance development and commercialization of various evolutionary and disruptive technologies in the dental implant industry.
MISSION – INNOVATIVE & PRACTICAL SOLUTIONS FOR THE DENTAL INDUSTRY
Visit: www.preferreddentalimplant.comwww.prefdent.com

On behalf of Preferred Dental Technologies Inc.
Erik Siegmund
Chief Executive Officer
Email: info@preferreddentalimplant.com
Tel: 204.691.3722
www.prefdent.com

This news release may contain forward-looking information which is not comprised of historical facts.
Forward-looking information involves risks, uncertainties and other factors that could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information. Forward-looking information in this news release may include, but is not limited to, the Company's objectives, goals or future plans. Factors that could cause actual results to differ materially from such forward-looking information include, but are not limited to, those risks set out in the Company's public documents filed on SEDAR. Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information, which only applies as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. The Company disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law. Neither The Canadian Securities Exchange nor its Regulations Services Provider (as that term is defined in the policies of The Canadian Securities Exchange accepts responsibility for the adequacy or accuracy of this release.

GlobeNewswire
globenewswire.com

Last updated on: 24/11/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.